Vitae Pharmaceuticals Completes Initial Public Offering

New York – October 10, 2014 – Cooley advised the underwriters on Vitae Pharmaceuticals, Inc.'s initial public offering. Vitae Pharmaceuticals is a clinical stage biotechnology company focused on discovering and developing novel, small molecule drugs to address significant unmet medical needs. The company now trades on The NASDAQ Global Stock Market under the symbol "VTAE."

The underwriters for the offering were Stifel, Nicolaus & Company, Incorporated, BMO Capital Markets Corp., JMP Securities LLC and Wedbush Securities Inc.

The Cooley corporate and securities team advising the underwriters was comprised of partners Bo Yaghmaie, Div Gupta and Stephane Levy, special counsel Tom Twedt and associates Steve Bielecki and Ariana Green.

Critical support for the offering was provided by partner Thomas Welk (compensation & benefits); partner Thomas Blinka and associate Sandhya Deo (intellectual property); partner Seth Rafkin and associate Andrew Turnbull (employment & labor); partners Wendy Goldstein and Natasha Leskovsek, special counsel Phil Mitchell and associate Jennifer Shanley (health care and life sciences regulatory); partner Kenneth Krisko and associate Jennifer Raab (life sciences transactions); partner Jeremy Naylor (tax); and associate Brendan Koeth (mergers and acquisitions).

About Cooley LLP

Cooley's attorneys solve legal issues for entrepreneurs, investors, financial institutions and established companies. Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and bet-the-company litigation, often where innovation meets the law.

Cooley has 800 lawyers across 11 offices in the United States and China.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.